HELVOET PHARMA IN INDIA

[BIZ: Alken, March 3]
Helvoet Pharma is investing EUR 14m in India to build a production facility. This will strengthen its market position in India and establish its first operational platform in Asia to further capitalize on its worldwide leadership in pharmaceutical rubber formulations. Helvoet Pharma’s decision to build its own plant has been made to leverage the country’s position as a center for excellence for generic and branded pharmaceutical products.

India has the highest number of US FDA-approved plants outside the USA and is expected to become a significant healthcare consumer market.

The brand new plant, fully equipped with state-of-the-art facilities built to Helvoet Pharma’s high standards, will be operational in 2012 and Helvoet Pharma will be spending EUR 14m over the next two years in its construction. Construction work for the green field production will start in the third quarter of this year. The new plant will be located near Poona in the Maharashtra state in the new developed industrial zone with a secure energy supply, good transport connections and access to trained personnel. If required, the new facility can be expanded modularly in the future.

Helvoet Pharma is a leading global supplier of primary and secondary pharmaceutical packaging components and was founded in 1970.

http://www.helvoetpharma.com/